In type 2 diabetes, dipeptidyl peptidase-4 inhibitors do not increase pancreatitis

被引：1
|
作者：
Morey-Vargas, Oscar L. [1 ]
Montori, Victor M. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 160卷 / 02期
关键词：
THERAPIES;
D O I：
10.7326/0003-4819-160-2-201401210-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dipeptidyl peptidase-4 inhibitors in type 2 diabetic elderly patient
    Doucet, Jean
    Bauduceau, Bernard
    Blickle, Jean-Frederic
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2011, 9 (02): : 157 - 162
  • [42] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Wei, Xin
    Bai, Yu
    Wang, Zhuo
    Zheng, Xiaohong
    Jin, Zening
    Liu, Xin
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [43] Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
    Ametov, A. S.
    Gusenbekova, D. G.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (08) : 85 - 89
  • [44] Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study
    Kim, Young-Gun
    Kim, Seirhan
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Kim, Hae Jin
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [45] Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapy
    Yen, Fu-Shun
    Chiang, Jen-Huai
    Pan, Chun-Wei
    Lin, Boniface J.
    Wei, James Cheng-Chung
    Hsu, Chih-Cheng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 140 : 279 - 287
  • [46] Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Health in Patients with Type 2 Diabetes Mellitus
    Lee, Dong-Hwa
    Kim, Kyong Young
    Yoo, Min Young
    Moon, Hansol
    Ku, Eu Jeong
    Oh, Tae Keun
    Jeon, Hyun Jeong
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [47] Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Yagi, Shusuke
    Aihara, Ken-ichi
    Akaike, Masashi
    Fukuda, Daiju
    Salim, Hotimah Masdan
    Ishida, Masayoshi
    Matsuura, Tomomi
    Ise, Takayuki
    Yamaguchi, Koji
    Iwase, Takashi
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Matsumoto, Toshio
    Sata, Masataka
    DIABETES & METABOLISM JOURNAL, 2015, 39 (04) : 342 - 347
  • [48] Incretin mimetics and dipeptidyl peptidase-4 inhibitors: Innovative treatment therapies for type 2 diabetes
    Davidson, Jaime A.
    Parente, Erika B.
    Gross, Jorge L.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (06) : 1039 - 1049
  • [49] Potential Impact of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Pathophysiology in Type 2 Diabetes Mellitus
    Davidson, Michael H.
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 56 - 65
  • [50] Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes May Reduce The Risk Of Autoimmune Diseases
    Kim, Seoyoung C.
    Schneeweiss, Sebastian
    Glynn, Robert J.
    Doherty, Michael
    Goldfine, Allison
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1133 - S1133
12345